Canakinumab
CAS: 914613-48-2
Ref. TM-T73695
| 1mg | 443,00 € | ||
| 2mg | 624,00 € | ||
| 5mg | 936,00 € | ||
| 10mg | 1.254,00 € | ||
| 25mg | 1.867,00 € | ||
| 50mg | 2.526,00 € | ||
| 100mg | 3.412,00 € |
Información del producto
- ACZ 885, Ilaris
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody.Canakinumab has been shown to inhibit human and chorioallantoic monkey IL-1β, with IC50 values of 43.6 and 40.8 pM, respectively.Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling. Canakinumab has anti-inflammatory activity, inhibiting inflammation associated with autoimmune diseases by neutralizing IL-1β signaling.Canakinumab has been used for the treatment of gout and coronary artery disease.
Propiedades químicas
Consulta técnica sobre: TM-T73695 Canakinumab
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
